The most frequent mutation in the PI3K pathway in GBM is loss of the PTEN lipid phosphatase, which results in unopposed signaling through PI3K and robust stimulation of Akt, especially in the context of EGFR activation [1]. The gene discussed is AKT1; the disease is glioblastoma.